CERS2 and Netherton syndrome: In addition, the fibroblasts from NS patients with mutation of SGPL1 showed an increase in very long-chain ceramides due to CerS2 activation, whereas S1P levels were below the limits of detection [75], suggesting that a rheostat of ceramide-S1P may contribute to the maintenance of podocyte function in NS.